Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (8), 1714-1717
- https://doi.org/10.1046/j.1538-7836.2003.00359.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?British Journal of Haematology, 2001
- Desmopressin: therapeutic limitations in children and adults with inherited coagulation disordersBritish Journal of Haematology, 2000
- Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesisBritish Journal of Haematology, 1996
- A Revised Classification of von Willebrand DiseaseThrombosis and Haemostasis, 1994
- Biological effects of a S/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand diseaseBlood Coagulation & Fibrinolysis, 1993
- Cloning and characterization of two cDNAs coding for human von Willebrand factor.Proceedings of the National Academy of Sciences, 1985
- Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's DiseaseBritish Journal of Haematology, 1981
- Genetics of classic von Willebrand's disease. I. Phenotypic variation within familiesBlood, 1979
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975